Impact Factor
3.42
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.18
421 total citations
h5-index
24
h5 depth signal
Cited share
79.3%
107 of 135
Total citations
421
Citation footprint
Metric signal
3.11
External metric anchor
Self-citation
3.1%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
221
China
145
Pakistan
88
Saudi Arabia
81
United States
69
Citing Fields of Research
Synthesis
367
Cancer Drugs
136
Phytochemicals
132
Protein Structure & Folding
113
Molecular Pharmacology
79
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,972
Articles tracked across the journal lifetime
Indexed publication set
135
107 cited publications
Last 12 months
98
8.9 publications/month
Open access share
2.0%
2 OA publications in the last year
Leading citing country
India
221 citing publications
Leading citing field
Synthesis
367 citing publications
Latest tracked publication
6 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2005-
v1n1, Jan. 2005-
Research Focus & Classification
Indexed Subjects
Synthesis
Protein Structure & Folding
Cancer Drugs
Phytochemicals
Neurodegenerative Disorders
Cancer, Autophagy & Apoptosis
Broad Categories
Chemistry
Synthesis
Protein Structure & Folding
Cancer Drugs
Phytochemicals
Endocrine Therapy
Molecular & Cellular Toxicology
MeSH Descriptors
Chemistry, Pharmaceutical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0115734064519687260917115009
Open DOI
Development of Pyrazole and Pyrazolo[4,5-b]pyridine Analogues with Potent Fungal Biofilm Inhibition Properties
Introduction: Fungal infections continue to pose significant health risks because of two factors, which include drug resistance and the restricted availability of treatment options. Molecular hybridization has been an effective method fo...
02
DOI 10.2174/0115734064490624260925075551
Open DOI
Design, Discovery, Synthesis, Molecular Docking, MD Simulation, and In Vitro Biological Evaluation of Thiazolidinedione-Clubbed Benzimidazole Hybrids as Potential Anticancer Agents
Introduction/Objective: Breast cancer is a major global health issue. A new series of thiazolidinedione-benzimidazole hybrid derivatives (TBZ1–15) was developed and tested for anticancer properties against the MCF-7 breast cancer cell li...
03
DOI 10.2174/0115734064509559260927160057
Open DOI
Organotin (IV)–4-(2-Thienyl) Butyric Acid Complexes Synergize with Vitamins D and E to Inhibit Breast Cancer Cell Proliferation
Introduction: Breast cancer (BC) treatment with conventional drugs is a medical challenge because of nonspecific targets, resistance, metastasis, and cancer relapse. Combination therapies incorporating bioactive compounds such as vitamin...
04
DOI 10.2174/0115734064519985260907100959
Open DOI
Pyrazinone Derivatives in Medicinal Chemistry: SAR Insights and Emerging Therapeutic Applications
Pyrazinones remain a comparatively underexplored class of nitrogen heterocycles, despite their recurrence in bioactive natural products and their emergence as a privileged scaffold engaging viral polymerases, kinases, proteases, and G-pr...
05
DOI 10.2174/0115734064511285260901071524
Open DOI
Nitrogen-Containing Heterocycles in Antibacterial Drug Discovery: Recent Advances and Structure-Activity Relationships
Antibiotic resistance has become a major global public health challenge, creating an urgent need for the development of new antimicrobial agents. This article reviews the latest research on nitrogen-heterocyclic antimicrobial agents, inc...
06
DOI 10.2174/0115734064513164260828103027
Open DOI
Computer-Aided Design of Novel Acrylamido Derivatives as Potential Oral Antidiabetic Agents
Introduction/Objective: Due to the significant problem of the pharmacokinetic properties of available oral antidiabetic drugs, it is necessary to focus on developing novel oral agents. This study utilized in silico methods to design nove...
07
DOI 10.2174/0115734064514052260819104552
Open DOI
Uracil-Quinazoline Hybrids: Cytotoxicity, Docking, MD, and DFT Studies
Introduction: Cancer remains a major cause of mortality worldwide; therefore, research continues to focus on the development of more effective therapeutic agents. Methods: In this study, the cytotoxic effects of a series of uracil-quinaz...
08
DOI 10.2174/0115734064503567260817161010
Open DOI
Pyrimidine Derivatives as Anticancer Agents: Structural Insights and SAR Studies
The structural variety and associated biological potential of pyrimidine derivatives have made them attractive to medicinal chemists. Due to the various biological activities of Pyrimidine derivatives and structural derivatives of DNA, m...
09
DOI 10.2174/0115734064504072260724092027
Open DOI
Arylsulfonylaminopyridines as Potential Epac Inhibitors: Design, Synthesis and Effects on Myocardial Strips
Introduction: Exchange proteins directly activated by cyclic AMP (Epac) represent a promising therapeutic target for developing novel cardiotropic agents. Epac-dependent signaling regulates intracellular calcium dynamics, intercellular c...
10
DOI 10.2174/0115734064521007260729061037
Open DOI
From Docking Scores to Biological Relevance: Strengthening Experimental Validation in Medicinal Chemistry Research
Bibliographical & Catalog Notes
Place of publication varies.
Description based on: Vol. 1, no. 3 (May 2005); title from cover.
Also issued online.